About
Technology
Issues
FAQ
Links
Official Page
Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.